Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review

References

• Benson MD. Amyloidosis. In: Scriver CR, Beaudet AK, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill; 1995. pp 4159–4191.
   Google Scholar
• Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002;346:1786–1791.
   PubMed Web of Science ®Google Scholar
• Robbins J. Thyroxine-binding proteins. Prog Clin Biol Res 1976;5:331–355.
   PubMedGoogle Scholar
• Connors LH, Richardson AM, Théberge R, Costello CE. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid 2000;7:54–69.
   PubMed Web of Science ®Google Scholar
• Benson MD. Amyloidosis. In: Scriver CR, Beaudet, AK, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited diseases. 8th ed. New York: McGraw-Hill; 2001. pp 5345–5378.
   Google Scholar
• Saraiva MJ. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat 2001;17:493–503.
   PubMed Web of Science ®Google Scholar
• Liepnieks JJ, Benson MD. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid 2007;14:277–282.
   PubMed Web of Science ®Google Scholar
• Connors LH, Théberge R, Skare J, Costello CE, Falk RH, Skinner M. A new transthyretin variant (Ser23Asn) associated with familial amyloidosis in a Portuguese patient. Amyloid 1999;6:114–118.
   PubMed Web of Science ®Google Scholar
• Mueller I, Gawaz M, Linke R, Zuern C, Steiner D, Altland K, Von Beckerath N, Weig H. Restrictive cardiomyopathy in inherited ATTR amyloidosis (TT-Ser23Asn) in a patient of German-Italian extraction. BMJ Case Reports [serial on the Internet]. 2010.
   Google Scholar
• Daoko J, Elnahar Y, El Kersh K, Mohammad N, Shamoon F. Cardiac MRI detection of a rare case of familial cardiac amyloidosis (Ser23Asn): Case report with literature review. Rep MedImag 2010;3:123–127.
   Google Scholar
• Sekijima Y, Dendle MA, Kelly JW. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis. Amyloid 2006;13:236–249.
   PubMed Web of Science ®Google Scholar
• Bispo M, Marcelino P, Freire A, Martins A, Mourão L, Barroso E. High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy. Transpl Int 2009;22:165–171.
   PubMed Web of Science ®Google Scholar
• Sharma P, Perri RE, Sirven JE, Zeldenrust SR, Brandhagen DJ, Rosen CB, Douglas DD, et al. Outcome of liver transplantation for familial amyloidotic polyneuropathy. Liver Transpl 2003;9:1273–1280.
   PubMed Web of Science ®Google Scholar
• Liepnieks JJ, Zhang LQ, Benson MD. Progression of transthyretin amyloid neuropathy after liver transplantation. Neurology 2010;75:324–327.
   PubMed Web of Science ®Google Scholar
• Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996;47:944–951.
   PubMed Web of Science ®Google Scholar
• Said G, Ropert A, Faux N. Length-dependent degeneration of fibers in Portuguese amyloid polyneuropathy: A clinicopathologic study. Neurology 1984;34:1025–1032.
   PubMed Web of Science ®Google Scholar
• Carvalho J, Coimbra A, Andrade C. Peripheral nerve fibre changes in asymptomatic children of patients with familial amyloid polyneuropathy. Brain 1976;99:1–10.
   Google Scholar
• Coimbra A, Andrade C. Familial amyloid polyneuropathy: An electron microscope study of the peripheral nerve in five cases. I. Interstitial changes. Brain 1971;94:199–206.
   PubMed Web of Science ®Google Scholar
• Thomas PK, King RH. Peripheral nerve changes in amyloid neuropathy. Brain 1974;97:395–406.
   PubMed Web of Science ®Google Scholar
• Dyck PJ, Lambert EH. Dissociated sensation in amylidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies. Arch Neurol 1969;20:490–507.
   PubMedGoogle Scholar
• Kernohan J, Woltman H. Amyloid neuritis. Archives of Neurology 1942;47:132–140.
   Google Scholar
• Kelly J, Lansbury PJ. A chemical approach to elucidate the mechanisms of transthyretin and B-protein amyloid fibril formation. Amyloid 1994;1:186–205.
   Web of Science ®Google Scholar
• Sabin TD. Classification of peripheral neuropathy: The long and the short of it. Muscle Nerve 1986;9:711–719.
   Google Scholar
• Ochs S, Brimijoin A. Axonal transport. In: Dyck Pea, editor. Peripheral Neuropathy. Philadelphia: WB Saunders; 1993. pp 331–360.
   Google Scholar
• Glaudemans AW, Slart RH, Zeebregts CJ, Veltman NC, Tio RA, Hazenberg BP, Dierckx RA. Nuclear imaging in cardiac amyloidosis. Eur J Nucl Med Mol Imaging 2009;36:702–714.
   PubMed Web of Science ®Google Scholar
• Wizenberg TA, Muz J, Sohn YH, Samlowski W, Weissler AM. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis. Am Heart J 1982;103:468–473.
   PubMed Web of Science ®Google Scholar
• Schiff S, Bateman T, Moffatt R, Davidson R, Berman D. Diagnostic considerations in cardiomyopathy: Unique scintigraphic pattern of diffuse biventricular technetium-99m-pyrophosphate uptake in amyloid heart disease. Am Heart J 1982;103:562–563.
   Google Scholar
• Sobol SM, Brown JM, Bunker SR, Patel J, Lull RJ. Noninvasive diagnosis of cardiac amyloidosis by technetium-99m-pyrophosphate myocardial scintigraphy. Am Heart J 1982;103:563–566.
   Google Scholar
• Willerson JT, Parkey RW, Bonte FJ, Lewis SE, Corbett J, Buja LM. Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy. Semin Nucl Med 1980;10:54–69.
   Google Scholar